Binge drinking and possibly, moderate alcohol intake, may trigger atrial fibrillation. Caffeine intake does not appear to be a trigger; although, some doctors still recommend that patients with atrial ...
Atrial fibrillation (AFib) is the most common form of irregular heartbeat (arrhythmia). People with AFib have many treatment options, including medications and medical procedures. However ...
Atrial fibrillation (Afib) is a type of cardiac arrhythmia, or abnormal heart rhythm, that is very common — and more prevalent than previously thought. A large study published in October 2024 in ...
Attempt to get rid of the atrial fibrillation altogether and restore and maintain normal heart rhythm. Allow the atrial fibrillation to persist while controlling the heart rate There are different ...
tsinghua-fib-lab/DoT’s past year of commit activity ...
The newest clinical guideline released by the ACC and the American Heart Association (AHA) provides new and updated recommendations for preventing and optimally managing atrial fibrillation (AFib).
Your daily soda may have bigger consequences than you think. A study published by the American Heart Association reveals a connection between artificially sweetened beverages, such as soda, and an ...
New late-breaking science from AHA 2023 sheds light on new treatments for patients with atrial fibrillation (AFib). In ARTESIA, the results of which were also published in the New England Journal of ...
Atrial fibrillation is a cardiac arrhythmia in which the upper chambers of the heart the atria beat irregularly and, often, rapidly. The condition occurs as a consequence of uncoordinated ...
Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study.
Atrial Fibrillation A Guide to Wearable ECG Smart Watches on sale, Atrial Fibrillation A Guide to Wearable ECG Smart Watches on sale, Samsung Announces FDA Cleared Irregular Heart Rhythm Notification ...
The safety of abelacimab as compared with a direct oral anticoagulant in patients with atrial fibrillation is unknown. Patients with atrial fibrillation and a moderate-to-high risk of stroke were ...